A survey of clinician perspectives on the management of catheter-related upper extremity deep vein thrombosis in patients with cancer
Patients with cancer have an increased risk of venous thromboembolism (VTE) compared to those without cancer [1]. Many risk factors contribute to the increased risk, among which a central venous catheter (CVC) is a major one [2]. CVCs are commonly used in patients with cancer to facilitate blood draws and administer chemotherapy or other supportive care treatment. Catheter-related upper extremity deep vein thrombosis (DVT) is a major complication of CVCs, with studies reporting a rate of symptomatic VTE of 7 % over 3 months in patients with active cancer and a new CVC [3].
Source: Thrombosis Research - Category: Hematology Authors: Tzu-Fei Wang, Aur élien Delluc, Andrea Cervi, Danny Hill, Michael J. Kovacs, Chantal Séguin, Tim Ramsay, Marc Carrier Tags: Letter to the Editors-in-Chief Source Type: research
More News: Cancer | Cancer & Oncology | Central Venous Catheterization | Chemotherapy | Hematology | Study | Thrombosis